Phase 3 GIST Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Olverembatinib in SDH-deficient GIST.
GIST
Ascentage Pharma Group Inc.40 enrolled1 locationNCT06640361
Not Yet Recruiting
Phase 3
A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to imatinib mesylate
Gastro-intestinal stromal tumour (GIST)
European Organisation for Research and Treatment of Cancer (EORTC)350 enrolled6 locationsACTRN12609000681257
Completed
Phase 2Phase 3
Providing parents in a neonatal intensive care unit with audiorecordings of their conversation with neonatologists: a randomised trial.
2) Maternal depression, anxiety, general health and parenting stress scales.1) Poor recall by mothers of information given by neonatologists.
Dr Andrew Johnson, The Townsville Hospital200 enrolled1 locationACTRN12606000478516
Completed
Phase 3
Adjuvant GIST Trial
Gastrointestinal stromal tumours (GIST)
AGITG400 enrolled1 locationACTRN12605000712606
Completed
Phase 3
Advanced GIST
Patients with unresectable or metastatic gastrointestional stromal tumors (GIST) expressing the kit receptor tyrosine kinase (CD117)
Novartis Australia946 enrolled19 locationsACTRN12605000138684